Intercede (IGP) AI Stock Analysis

• Market Cap: £46.93M
• Dividend Yield: N/A
• Average Volume (3M): 120.69K
• Price to Earnings (P/E): 20.8
• Beta (1Y): 0.85
• Revenue Growth: -19.19%
• EPS Growth: -41.12%
• Country: UK
• Employees: 108
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Application
• EPS (TTM): 0.02
• Shares Outstanding: 60,162,544
• 10 Day Avg. Volume: 233,929
• 30 Day Avg. Volume: 120,689
• PEG Ratio: -0.67
• Price to Book (P/B): 4.93
• Price to Sales (P/S): 4.74
• P/FCF Ratio: 36.45
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 0.06
• Revenue Forecast (FY): £18.70M

• Rating: 64 Neutral
• Price Target: 104.00 p ▼(-17.46% Downside)
• Action: Reiterated Date: 12/07/25
• Date: Action: Reiterated 12/07/25

Intercede's overall stock score is driven by its strong corporate events and stable financial performance, despite technical weaknesses. The company's ability to secure significant contracts and insider confidence are positive indicators, but technical analysis suggests caution due to bearish trends.

Positive Factors

High gross and net margins

Extremely high gross margins (above 96%) and a healthy net margin (~22.9%) indicate structural pricing power and low incremental costs for delivering software and credentials. This durable margin profile supports reinvestment in R&D and support, funds operations through cycles, and sustains profitability even if revenue growth moderates over the next several months.

Conservative balance sheet / low leverage

Very low leverage and a strong equity ratio give the company durable financial flexibility to fund working capital, absorb contract timing swings, and pursue selective investments or partnerships without needing immediate external financing. This reduces solvency risk and supports multi-month resilience in operating plans.

Contract wins and insider confidence

Material contract wins and renewals worth several million demonstrate a pipeline of multi-period, potentially recurring revenue and longer-term customer relationships. Executive share purchases signal management alignment and confidence, reinforcing durable revenue visibility and incentivizing execution over the medium term.

Negative Factors

Material revenue decline

A near-18% year-over-year revenue drop signals weakening top-line momentum that can undermine operating leverage and long-term growth. Persisting declines would force higher sales and marketing spend to regain share or drive pricing pressure, making it harder to sustain investment and long-term expansion over the next several months.

Weak free cash flow conversion

A steep 67% fall in free cash flow growth and FCF-to-income of 0.57 indicate diminished ability to convert profits into cash. This limits scope for organic investment, reduces buffers against operational shocks, and constrains capital allocation choices (R&D, hiring, M&A) in the medium term unless cash conversion recovers.

Declining return on equity

A declining ROE to 23.8% suggests the company is becoming less efficient at turning equity into profits, which may reflect slowing revenue or pressure on margins. If this trend continues it can signal deteriorating capital efficiency and weaker long-term shareholder returns, limiting reinvestment effectiveness.

Intercede Business Overview & Revenue Model

Company Description

Intercede Group plc, a cybersecurity company, engages in identity, credential management, and secure mobility business to enable digital trust in the United Kingdom, rest of Europe, the United States, and internationally. The company offers MyID, a credential management system for cyber secure digital identity that allows organizations to deploy digital identities to a range of secure devices; MyID Professional, an identity management software solution that enables enterprises to replace insecure passwords across their workforce with the strong user authentication – smart cards, or USB tokens with public key infrastructure certificates; and MyID Enterprise, a software solution for large organizations and governments to deploy and manage digital identities to a range of secure devices. In addition, it provides MyID PIV, a software solution for federal agencies that issue and manage secure digital identities to federal employees. The company serves government and federal; aerospace and defense; finance and banking; healthcare and critical infrastructure; energy and utilities; manufacturing and industry; and military and police institutes. The company was formerly known as Optionsilver plc and changed its name to Intercede Group plc in December 2000. The company was founded in 1992 and is headquartered in Lutterworth, the United Kingdom.

How the Company Makes Money

Intercede makes money primarily by selling and supporting its identity and credential management software. Key revenue streams include: (1) Software licensing/subscriptions for its MyID platform and related modules, where customers pay for the right to use the software (often sized by users, devices, or managed credentials) and, in some cases, recurring subscription fees depending on contract structure. (2) Maintenance and support contracts, typically recurring, where customers pay annual/ongoing fees for product updates, security patches, and technical support. (3) Professional services, where Intercede charges for implementation, integration, configuration, and advisory work to deploy MyID into customer environments (including integration with directories, PKI, access management stacks, and enterprise applications). Revenue is influenced by the mix of new deployments versus renewals/expansions in existing accounts, and by channel/partner-led sales where systems integrators or technology partners help deliver deployments; specific named partnerships or their financial contribution: null.

Intercede Financial Statement Overview

Summary

Intercede demonstrates strong profitability and operational efficiency, as evidenced by high margins. However, the recent revenue decline and significant drop in free cash flow growth are areas of concern. The balance sheet remains strong with low leverage, but the decrease in return on equity suggests potential challenges in maintaining high returns. Overall, the company is financially stable but faces growth challenges.

Income Statement

Intercede's income statement shows a strong gross profit margin, consistently above 96%, indicating efficient cost management. However, the company experienced a significant revenue decline of 17.66% in the latest year, which is a concern. Despite this, the net profit margin remains healthy at 22.89%, suggesting profitability. The EBIT and EBITDA margins are also robust, reflecting operational efficiency.

Balance Sheet

The balance sheet reveals a stable financial position with a low debt-to-equity ratio of 0.036, indicating low leverage. The equity ratio of 59.37% suggests a strong capital structure. However, the return on equity has decreased to 23.80%, which may indicate reduced efficiency in generating returns from equity.

Cash Flow

Cash flow analysis shows a significant decline in free cash flow growth by 67.18%, which is concerning. The operating cash flow to net income ratio is 0.71, indicating moderate cash generation relative to net income. The free cash flow to net income ratio is 0.57, suggesting some challenges in converting income into cash flow.

Breakdown	TTM	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement
Total Revenue	17.38M	17.71M	19.96M	12.11M	9.93M	10.96M
Gross Profit	16.25M	17.19M	19.40M	11.71M	9.73M	10.73M
EBITDA	4.78M	5.17M	6.11M	1.06M	713.00K	1.91M
Net Income	3.63M	4.05M	6.02M	1.31M	723.00K	1.53M
Balance Sheet
Total Assets	25.59M	28.69M	25.69M	17.44M	12.93M	13.01M
Cash, Cash Equivalents and Short-Term Investments	17.82M	18.67M	17.23M	8.33M	7.79M	8.03M
Total Debt	1.15M	619.00K	804.00K	465.00K	756.00K	1.11M
Total Liabilities	9.13M	11.66M	12.52M	10.41M	7.42M	8.26M
Stockholders Equity	16.46M	17.03M	13.18M	7.03M	5.51M	4.75M
Cash Flow
Free Cash Flow	4.33M	2.30M	9.27M	2.79M	77.00K	4.14M
Operating Cash Flow	4.45M	2.88M	9.63M	2.86M	110.00K	4.24M
Investing Cash Flow	-395.00K	-856.00K	-358.00K	-2.08M	-33.00K	-95.00K
Financing Cash Flow	-2.47M	-529.00K	-333.00K	-294.00K	-372.00K	-791.00K

Intercede Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 126.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:IGP, the sentiment is Negative. The current price of 126 is above the 20-day moving average (MA) of 106.85, above the 50-day MA of 115.20, and below the 200-day MA of 147.69, indicating a bearish trend. The MACD of -6.44 indicates Positive momentum. The RSI at 24.25 is Positive, neither overbought nor oversold. The STOCH value of 27.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:IGP.

Intercede Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SPSC	72 Outperform	£62.84M	3.74	35.56%	4.16%	―	―
ACSO	70 Outperform	£93.21M	54.18	2.93%	―	-3.95%	16.87%
GBG	70 Outperform	£472.70M	71.10	1.53%	1.73%	-0.18%	11.49%
IGP	64 Neutral	£46.93M	20.75	23.08%	―	-19.19%	-41.12%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
NCC	54 Neutral	£341.83M	26.54	7.75%	2.16%	―	―
COIN	41 Neutral	£14.50M	-35.35	-19.77%	―	―	―

Intercede Corporate Events

Intercede Warns on FY26 Revenue but Reaffirms 2027 Growth Target Amid Shift to Subscriptions

Intercede expects continued growth in annual recurring revenue for the year to 31 March 2026 as it accelerates a strategic shift from perpetual licences to subscription-based digital identity software, which is designed to improve revenue quality and predictability. The company remains debt-free with stronger-than-expected year-end cash, underscoring balance sheet resilience.

However, full-year FY26 revenue is anticipated to come in about 8–9% below market expectations and adjusted EBITDA 15–18% lower, as procurement delays, particularly in the U.S., and customer caution amid geopolitical uncertainty, including the Middle East conflict, pushed orders into later periods rather than cancelling them. Management has reaffirmed its FY27 revenue target of £21m, citing a robust pipeline, improved order intake in the second half and ongoing subscription adoption, signalling that timing issues rather than structural demand weakness are weighing on near-term performance but leaving its medium-term growth trajectory intact.

The most recent analyst rating on (GB:IGP) stock is a Hold with a £100.00 price target. To see the full list of analyst forecasts on Intercede stock, see the GB:IGP Stock Forecast page.

Intercede Issues New Shares After Employee Option Exercise, Updates Voting Rights

Intercede Group has issued 200,000 new ordinary shares following the exercise of employee share options under its Enterprise Management Incentive Plan, with admission of the new shares to trading on AIM expected around 22 January 2026. The issuance increases the company’s total share capital to 60,536,452 ordinary shares, of which 60,162,546 carry voting rights after accounting for treasury shares, providing an updated denominator for investors monitoring disclosure thresholds under UK transparency rules and modestly expanding the company’s equity base through employee-related incentives.

The most recent analyst rating on (GB:IGP) stock is a Hold with a £126.00 price target. To see the full list of analyst forecasts on Intercede stock, see the GB:IGP Stock Forecast page.

Intercede Issues New Shares After Employee Option Exercise, Updates Voting Rights

Intercede Group has issued 150,000 new ordinary shares following the exercise of employee share options under its Enterprise Management Incentive Plan, with the new shares expected to be admitted to trading on AIM around 2 January 2026. After admission, the company will have 60,336,452 ordinary shares in issue, of which 373,906 are held in treasury, resulting in 59,962,546 voting rights, a figure shareholders can use to assess disclosure obligations under UK transparency rules.

The most recent analyst rating on (GB:IGP) stock is a Hold with a £142.00 price target. To see the full list of analyst forecasts on Intercede stock, see the GB:IGP Stock Forecast page.